Ajanta Pharma records India's largest CPR campaign, Gets Recognised by Asia Book of Records

Ajanta organized 1000+ workshops across India where live demo/training was imparted to 27,000+ participants on Life Saving technique CPR by 1000+ highly trained doctors of the country. The campaign was conducted between April 2022 and February 2023 and was attended by doctors, paramedics, patients, and the general public.

As per the Global Burden of Disease study, the age-standardized CVD death rate of 272 per 100,000 population in India is higher than the global average of 235. Every minute 112 Indians are estimated to succumb to cardiac arrest. Most cardiac arrests occur outside the hospital, and the chances of survival decrease by 7 to 10 minutes with each passing minute. However, intervention with early CPR is associated with better prognosis and survival outcomes.

“Unfortunately, 92% of sudden cardiac arrest victims die before reaching the hospital, but statistics prove that if more people knew CPR, more lives could be saved. It was with this aim of empowering the public that we initiated the largest CPR mass awareness campaign for saving lives in case of emergencies,” explained Mr. Pourus Vakil, India Business Head, Ajanta Pharma.

Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and emerging markets, a generic business in US, and an institution business in Africa. Many of the company’s products are 1st to market and are leading in their sub-therapeutic segments.

Asia Book of Records is a platform where the record holders of all major National ‘Book of Records’ including ‘India Book of Records’, 'Vietnam Book of Records', 'Indo-China Book of Records’, ‘Laos Book of Records’ and ‘Nepal Book of Records’ meet to compare, compete and claim the title of 'Asia Book of Records' Holder. Today, the Asia Book of Records is having a strong database of 40,000 entries.